Home > Food & Beverages > Nutraceuticals > Amino Acids > L-carnitine Market

L-carnitine Market Share

Report ID: GMI6328
Published Date: Jul 2023
Report Format: PDF

Download Free Sample

L-carnitine Market Share

Some key participants in the L-carnitine market include

Lonza
Cayman Chemical
Kaiyuan Hengtai Nutrition Co., Ltd
Tokyo Chemical Industry Co., Ltd
Biosint S.p.A
Northeast Medicines Group Co., Ltd. (NEPG)
Merck KGaA
Ceva
Huanggang Huayang Medicines Co. Ltd
Xinxiang Kangjian Chemical Co., Ltd
ChengDa PharmaCeuticals Co., Ltd
HuBeiYuancheng Saichuang Technology Co. Ltd
China Qingdao Hongjin Chemical Co., Ltd
Shanghai Danfan Network Science & Technology Co., Ltd
Tokyo Chemical Industry

These companies concentrate on strategic partnerships, new product launches, and commercialization efforts for market growth. Furthermore, they make huge investments in research & development to launch advanced products and gain maximum market revenue.

Authors: Kiran Pulidindi, Kunal Ahuja

Frequently Asked Questions (FAQ) :

The market size of L-carnitine was reached USD 206 million in 2023 and is set to grow at over 5% CAGR from 2024 to 2032, due to the surging consumer awareness about health and fitness worldwide.

The feed-grade segment recorded 68% of the L-carnitine market share in 2022, owing to the surging need to strengthen the immune system, boost growth promotion and improve the antioxidant effects.

North America market size recorded USD 63.9 million in 2022 and is set to witness significant traction through 2032, attributed to the changing consumer preferences in the region.

Lonza, Cayman Chemical, Kaiyuan Hengtai Nutrition Co., Ltd., Tokyo Chemical Industry Co., Ltd, Biosint S.p.A., Northeast Medicines Group Co., Ltd. (NEPG), Merck KGaA, Ceva, Huanggang Huayang Medicines Co. Ltd., and Xinxiang Kangjian Chemical Co., Ltd. are some major L-carnitine producers.